Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Systems team. Lead a comprehensive and innovative outreach programme the promotes engagement with the collections including organising exhibitions and events. Identify and develop opportunities to integrate
-
an established group of researchers. The nature and structure of the Phase 2 Research Ireland Centre programme allows for Post-Doctoral Researchers to work and gain valuable experience in a varied & research-rich
-
of Computer Science and Information Technology, to work on developing interactive software to create schedules. Prior experience in constraint programming, schedule generation and software development are essential
-
) are core values under our UCC Strategic Plan 2023-2028. UCC holds a Silver Athena SWAN award in recognition of our commitment to advancing equality in higher education. We value diversity as
-
Inclusion (EDI) are core values under our UCC Strategic Plan 2023-2028. UCC holds a Silver Athena SWAN award in recognition of our commitment to advancing equality in higher education. We value diversity as
-
an enthusiastic and innovative lecturer in Physiotherapy. The successful candidate will play a key role in teaching and supporting the 2-year MSc Physiotherapy programme. The successful candidate will have a
-
focused on efficiency and fault-tolerance in wireless Time Sensitive Networks, incorporating scheduling, clock synchronisation, and fault tolerance mechanisms across 5G-TSN networks. We plan to devise novel
-
into the Ireland’s Nature Restoration Plan. MaREI is a key research centre within UCC’s Sustainability Institute (formerly the Environmental Research Institute), which is an internationally recognised Institute
-
Permanent Whole-Time Post UCC wishes to appoint to the role of Lectureship in Public Health Nursing. The appointee will be expected to contribute to teaching, assessment and programme development
-
BACtheWINNER team. The main aim of this research programme is to develop bacteriocins as novel antimicrobials/therapeutics by solving the current challenges associated with their implementation, such as low